Evidence map›Paper›PMID 39898550›Full record

ArticleNucleic acids research2025

Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance.

Mélodie Latour, Lauren Kwiatek, Anne-Marie Landry-Voyer, François Bachand

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mélodie LatourRNA Group, Department of Biochemistry & Functional Genomics, Université de Sherbrooke, Sherbrooke, Québec, J1E 4K8, Canada.
Lauren KwiatekRNA Group, Department of Biochemistry & Functional Genomics, Université de Sherbrooke, Sherbrooke, Québec, J1E 4K8, Canada.
Anne-Marie Landry-VoyerRNA Group, Department of Biochemistry & Functional Genomics, Université de Sherbrooke, Sherbrooke, Québec, J1E 4K8, Canada.
François BachandRNA Group, Department of Biochemistry & Functional Genomics, Université de Sherbrooke, Sherbrooke, Québec, J1E 4K8, Canada.ORCID 0000-0003-3753-8966

Funding

CIHRFonds de recherche du Québec - Santé
6 · The paper itself

Abstract

Most eukaryotic genomes are transcribed pervasively, thereby producing an array of long non-coding RNAs (lncRNAs) in addition to protein-coding mRNAs. A large fraction of these lncRNAs is targeted by polyadenylation-dependent decay via the poly(A)-binding protein nuclear 1 (PABPN1) and the RNA exosome. Yet, how PABPN1 contributes to nuclear RNA surveillance by facilitating lncRNA turnover by the RNA exosome remains largely unclear. Here, we show that PABPN1 is important for the nuclear retention of polyadenylated lncRNAs, such that PABPN1 loss of function allows target lncRNAs to evade nuclear decay, leading to cytoplasmic accumulation. Interestingly, we found that another nuclear PABP, ZC3H14, functions antagonistically to PABPN1 and the poly(A)-tail exosome targeting (PAXT) connection in the control of nuclear lncRNA turnover. Collectively, our findings disclose the critical interplay between two conserved nuclear PABPs, PABPN1 and ZC3H14, in RNA surveillance via the control of nuclear RNA export.

Indexed as

Cell NucleusPoly(A)-Binding Protein IPoly(A)-Binding ProteinsRNA, Long NoncodingRNA, NuclearExosome Multienzyme Ribonuclease ComplexHeLa CellsHumansPolyadenylationRNA-Binding ProteinsRNA, MessengerRNA StabilityExosome Multienzyme Ribonuclease ComplexPABPN1 protein, humanPoly(A)-Binding Protein IPoly(A)-Binding ProteinsRNA-Binding ProteinsRNA, Long NoncodingRNA, MessengerRNA, Nuclear

Identifiers

PMID39898550
PMCPMC11788927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.